![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, November 03, 2011 4:23:17 PM
If BIEL followed the recommendations given over these past years (jeez has it been that long?) by FDA (high level), translated them into more detailed requirements (using their consultants), then were able to submit documentation to FDA that shows that they meet these requirements, we're good.
But it's how BIEL INTERPRETED the recommendations from FDA. FDA will never tell you exactly what is required for approval/clearance, so hopefully (and this is what we are all betting on) BIEL got it right this time, that is, the documentation that supports the detailed recommendations put for by the consultant, which are in alighment with FDA's higher level recommendations.
In the end it's a crap shoot, really, for any company. This is part of the problem. Because the requirements are not black and white, they are interpreted by each company, as well as each inspector.
Depends on the day, depends on the mood...not a real 'scientific' approach.
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM